Itoh S and Navia MA |
Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus). |
1995 |
Protein Sci. |
pmid:8563622
|
Tanida I et al. |
Yeast Cls2p/Csg2p localized on the endoplasmic reticulum membrane regulates a non-exchangeable intracellular Ca2+ pool cooperatively with calcineurin. |
1996 |
FEBS Lett. |
pmid:8566225
|
Charters AR et al. |
Developmental expression of FK506 binding proteins and calcineurin in rat brain. |
1995 |
Biochem. Soc. Trans. |
pmid:8566310
|
Castillo Lugo JA |
Clinical and experimental immunosuppression. |
1995 May-Jun |
Bol Asoc Med P R |
pmid:8573248
|
Vilquin JT et al. |
FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. |
1995 |
Hum. Gene Ther. |
pmid:8573612
|
Sano T et al. |
FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma. |
1995 |
Eur. Respir. J. |
pmid:8575571
|
Wesselborg S et al. |
Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp). |
1996 |
J. Biol. Chem. |
pmid:8576111
|
Sekigawa I et al. |
Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120. |
1995 |
J. Clin. Immunol. |
pmid:8576317
|
Hemenway CS et al. |
vph6 mutants of Saccharomyces cerevisiae require calcineurin for growth and are defective in vacuolar H(+)-ATPase assembly. |
1995 |
Genetics |
pmid:8582630
|
Gonschior AK et al. |
Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay. |
1995 |
Ther Drug Monit |
pmid:8585114
|
Büttemeyer R et al. |
Peripheral nerve allograft transplantation with FK506: functional, histological, and immunological results before and after discontinuation of immunosuppression. |
1995 |
Ann Plast Surg |
pmid:8585683
|
Takeda Y et al. |
Effect of FK 506 on the expression of endothelin receptor mRNA in the vasculature. |
1995 |
J. Cardiovasc. Pharmacol. |
pmid:8587392
|
Goodall T et al. |
FK506-induced endothelin release by cultured rat mesangial cells. |
1995 |
J. Cardiovasc. Pharmacol. |
pmid:8587453
|
Soldin SJ |
Receptor (immunophilin-binding) assay for immunosuppressive drugs. |
1995 |
Ther Drug Monit |
pmid:8588223
|
Thomson AW et al. |
Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. |
1995 |
Ther Drug Monit |
pmid:8588225
|
Fung JJ and Starzl TE |
FK506 in solid organ transplantation. |
1995 |
Ther Drug Monit |
pmid:8588226
|
Jusko WJ |
Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring. |
1995 |
Ther Drug Monit |
pmid:8588227
|
McMaster P et al. |
Therapeutic drug monitoring of tacrolimus in clinical transplantation. |
1995 |
Ther Drug Monit |
pmid:8588228
|
Jusko WJ et al. |
Consensus document: therapeutic monitoring of tacrolimus (FK-506). |
1995 |
Ther Drug Monit |
pmid:8588229
|
Lohse DL et al. |
Insights derived from the structures of the Ser/Thr phosphatases calcineurin and protein phosphatase 1. |
1995 |
Structure |
pmid:8590008
|
Cardenas ME et al. |
Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. |
1995 |
Curr. Opin. Nephrol. Hypertens. |
pmid:8591053
|
Dhar DK et al. |
FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver. |
1996 |
J. Surg. Res. |
pmid:8592405
|
Sakane T et al. |
[A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions]. |
1995 |
Ryumachi |
pmid:8594659
|
Taylor PJ et al. |
Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. |
1996 |
Clin. Chem. |
pmid:8595724
|
Hammond TG and Kind CN |
Pancreatic and nephrotoxicity of immunomodulator compounds. |
1995 |
Toxicol. Lett. |
pmid:8597171
|
Dan Y et al. |
IL-3 augments TCR-mediated responses of type 2 CD4 T cells. |
1996 |
J. Immunol. |
pmid:8598473
|
Ma J et al. |
Rectification of skeletal muscle ryanodine receptor mediated by FK506 binding protein. |
1995 |
Biophys. J. |
pmid:8599646
|
Beretta L et al. |
Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. |
1996 |
EMBO J. |
pmid:8599949
|
Inomata Y et al. |
The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. |
1996 |
Transplantation |
pmid:8600632
|
Gruessner RW et al. |
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. |
1996 |
Transplantation |
pmid:8600635
|
Rifai N et al. |
The role of lipoproteins in the transport and uptake of cyclosporine and dihydro-tacrolimus into HepG2 and JURKAT cell lines. |
1996 |
Clin. Biochem. |
pmid:8601324
|
Lake KD and Canafax DM |
Important interactions of drugs with immunosuppressive agents used in transplant recipients. |
1995 |
J. Antimicrob. Chemother. |
pmid:8601538
|
Vilquin JT et al. |
Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. |
1996 |
J. Cell Biol. |
pmid:8601607
|
Murao K et al. |
Immunosuppressant agent FK506 stimulates growth hormone (GH) secretion and gene expression of hypothalamic GH-releasing hormone in the rat. |
1996 |
Endocrinology |
pmid:8603582
|
Fay JW et al. |
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. |
1996 |
Blood |
pmid:8605372
|
Greeno EW et al. |
Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. |
1996 |
Transfusion |
pmid:8607158
|
Suzuki S et al. |
Pure red cell aplasia induced by FK506. |
1996 |
Transplantation |
pmid:8607191
|
Busuttil RW et al. |
General guidelines for the use of tacrolimus in adult liver transplant patients. |
1996 |
Transplantation |
pmid:8607197
|
Esquivel CO et al. |
Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. |
1996 |
Transplantation |
pmid:8607198
|
Peters KP et al. |
The automatic search for ligand binding sites in proteins of known three-dimensional structure using only geometric criteria. |
1996 |
J. Mol. Biol. |
pmid:8609611
|
Singh N et al. |
Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of microbial etiologies. |
1996 |
Transplantation |
pmid:8610349
|
Yanchar NL et al. |
Tacrolimus (FK506)--its effects on intestinal glucose transport. |
1996 |
Transplantation |
pmid:8610392
|
Hariharan S et al. |
Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity. |
1996 |
Transplantation |
pmid:8610411
|
Cacciarelli TV et al. |
Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. |
1996 |
Transplantation |
pmid:8610416
|
Osowski CL et al. |
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients. |
1996 |
Transplantation |
pmid:8610430
|
Johnson MW et al. |
Hepatitis C viral infection in liver transplantation. |
1996 |
Arch Surg |
pmid:8611094
|
Furth S et al. |
Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients. |
1996 |
Pediatr. Nephrol. |
pmid:8611359
|
Brousse N and Goulet O |
Small bowel transplantation. |
1996 |
BMJ |
pmid:8611766
|
Galat A |
A note on circular-dichroic-constrained prediction of protein secondary structure. |
1996 |
Eur. J. Biochem. |
pmid:8612612
|
Márquez JA and Serrano R |
Multiple transduction pathways regulate the sodium-extrusion gene PMR2/ENA1 during salt stress in yeast. |
1996 |
FEBS Lett. |
pmid:8612770
|
Stoller G et al. |
An 11.8 kDa proteolytic fragment of the E. coli trigger factor represents the domain carrying the peptidyl-prolyl cis/trans isomerase activity. |
1996 |
FEBS Lett. |
pmid:8612805
|
Pham SM et al. |
A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: intermediate-term results. |
1996 |
J. Thorac. Cardiovasc. Surg. |
pmid:8614136
|
|
|
|
|
pmid:8615615
|
Igarashi O et al. |
B7-1 synergizes with interleukin-12 in interleukin-2 receptor alpha expression by mouse T helper 1 clones. |
1996 |
Eur. J. Immunol. |
pmid:8617295
|
Rappersberger K et al. |
Clearing of psoriasis by a novel immunosuppressive macrolide. |
1996 |
J. Invest. Dermatol. |
pmid:8618008
|
Li W and Handschumacher RE |
Regulation of the nuclear factor of activated T cells in stably transfected Jurkat cell clones. |
1996 |
Biochem. Biophys. Res. Commun. |
pmid:8619834
|
Panyi G et al. |
Immunosuppressors inhibit voltage-gated potassium channels in human peripheral blood lymphocytes. |
1996 |
Biochem. Biophys. Res. Commun. |
pmid:8619842
|
Kiang D et al. |
Cloning the gene encoding Schistosoma mansoni p50, an immunophilin. |
1996 |
Gene |
pmid:8621074
|
Roth D et al. |
A prospective study of hepatitis C virus infection in renal allograft recipients. |
1996 |
Transplantation |
pmid:8623154
|
Koprak S et al. |
Depletion of the mature CD4+8- thymocyte subset by FK506 analogs correlates with their immunosuppressive and calcineurin inhibitory activities. |
1996 |
Transplantation |
pmid:8623162
|
Ciancio G et al. |
Current advantage of FK 506 in cadaveric kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623207
|
Pham SM et al. |
Tacrolimus (FK 506) in clinical cardiac transplantation: a five-year experience. |
1996 |
Transplant. Proc. |
pmid:8623208
|
Satomura K et al. |
Pharmacokinetics of FK 506 in living-related liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623209
|
Loss M et al. |
Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy. |
1996 |
Transplant. Proc. |
pmid:8623210
|
Bechstein WO et al. |
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623211
|
Sher LS et al. |
Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623212
|
Millis JM et al. |
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. |
1996 |
Transplant. Proc. |
pmid:8623213
|
Washburn WK et al. |
Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8623214
|
Regazzi MB et al. |
Interaction between FK 506 and diltiazem in an animal model. |
1996 |
Transplant. Proc. |
pmid:8623215
|
Hashikura Y et al. |
Immunosuppressant switching between cyclosporine and tacrolimus after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623218
|
Tomikawa S et al. |
Immunosuppressive effects of bactobolamine in vitro and in vivo. |
1996 |
Transplant. Proc. |
pmid:8623223
|
Nakajima H and Oka T |
The inhibition of T-cell-receptor-induced Fas ligand upregulation by cyclosporine and FK 506. |
1996 |
Transplant. Proc. |
pmid:8623224
|
Ko S et al. |
Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation. |
1996 |
Transplant. Proc. |
pmid:8623229
|
Morozumi K et al. |
A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar? |
1996 |
Transplant. Proc. |
pmid:8623232
|
Takada S et al. |
HGF prevents tacrolimus (FK 506)-induced nephrotoxicity in SHR rats. |
1996 |
Transplant. Proc. |
pmid:8623236
|
Nakai T et al. |
Immunosuppressive mechanism and immune tolerance of FK 506 in rat small bowel transplantation. |
1996 |
Transplant. Proc. |
pmid:8623237
|
Jin MB et al. |
Protective effect of FK 506 on hepatic energy metabolism in warm ischemic canine livers induced by total hepatic vascular exclusion. |
1996 |
Transplant. Proc. |
pmid:8623243
|
Smit JA et al. |
Induction of primate TH2 lymphokines to suppress TH1 cells. |
1996 |
Transplant. Proc. |
pmid:8623334
|
Tanaka M et al. |
Tacrolimus (FK 506)-dependent tolerance after liver and heart xenotransplantation: inhibition of humoral response and acceptance of donor organs. |
1996 |
Transplant. Proc. |
pmid:8623341
|
Ye Q et al. |
Functional analysis of hamster kidney xenografts in the rat: possible functional incompatibility and adaptation of hamster kidney grafts in a xenogenic rat environment. |
1996 |
Transplant. Proc. |
pmid:8623350
|
Namii Y et al. |
Tetrahydropyranyladriamycin with FK 506 combination therapy for hamster-to-rat-concordant xenotransplantation. |
1996 |
Transplant. Proc. |
pmid:8623358
|
Valdivia LA et al. |
Prolonged survival of hearts obtained from chimeric donors in a mouse to rat xenotransplant model. |
1996 |
Transplant. Proc. |
pmid:8623371
|
Wakizaka Y et al. |
Xenotransplantation of hamster liver into Gunn rats reserves congenital hyperbilirubinemia. |
1996 |
Transplant. Proc. |
pmid:8623372
|
Pan F et al. |
Effect of tacrolimus and splenectomy on engraftment and GVHD after bone marrow xenotransplantation in the reciprocal hamster to rat animal models. |
1996 |
Transplant. Proc. |
pmid:8623373
|
Fukushima N et al. |
Histological findings in heart grafts after orthotopic pig to baboon cardiac transplantation. |
1996 |
Transplant. Proc. |
pmid:8623400
|
Takeda M et al. |
Methotrexate in rescue therapy for xenotransplanted lungs in primates. |
1996 |
Transplant. Proc. |
pmid:8623402
|
Andereggen E et al. |
Immunohistological study of islet xenograft rejection in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623420
|
Horimoto H et al. |
Hepatocyte xenotransplantation for Nagase's analbuminemic rats: the effect of FK506. |
1996 |
Transplant. Proc. |
pmid:8623421
|
Sung RS et al. |
Survival of human islet xenografts irradiated with ultraviolet B in diabetic rats. |
1996 |
Transplant. Proc. |
pmid:8623427
|
Pirenne J et al. |
Addition of the colon to small bowel grafts causes lethal graft-versus-host disease in FK 506-treated pigs. |
1996 |
Transplant. Proc. |
pmid:8623447
|
Harrison DM et al. |
Reduction in hospital stay after liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623451
|
Andrews WS et al. |
Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623452
|
Ketel BL et al. |
Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation. |
1996 |
Transplant. Proc. |
pmid:8623453
|
Kyo M et al. |
Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin. |
1996 |
Transplant. Proc. |
pmid:8623457
|
D'Silva M et al. |
Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623467
|
Pirenne J et al. |
Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623472
|
Ciancio G et al. |
Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. |
1996 |
Transplant. Proc. |
pmid:8623473
|
D'Silva M et al. |
Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623476
|
Klintmalm GB |
Clinical use of FK 506 in liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623484
|
Butt TR et al. |
Molecular basis of immunosuppressive drug action: regulation of steroid receptor-mediated transcription by FK 506. |
1996 |
Transplant. Proc. |
pmid:8623486
|